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Abstract 
The Enteric Nervous System (ENS) is a complex network constituted of neurons and glial 
cells that ensures the intrinsic innervation of the gastrointestinal tract. ENS cells originate 
from vagal and sacral neural crest cells that are initially located at the border of the neural 
tube. In birds, sacral neural crest cells (sNCCs) first give rise to an extramural ganglionated 
structure (the so-called Nerve of Remak (NoR)) and to the pelvic plexus. Later, sNCCs enter 
the colon mesenchyme to colonize and contribute to the intrinsic innervation of the caudal 
part of the gut. However, no specific sNCC marker has been described. Here, we report the 
expression pattern of Prospero-related homeobox 1 (PROX1) in the developing chick colon. 
PROX1 is a homeobox domain transcription factor that plays a role in cell type specification 
in various tissues. Using in situ hybridization and immunofluorescence techniques, we 
showed that PROX1 is expressed in sNCCs localized in the NoR and in the pelvic plexus. 
Then, using real-time quantitative PCR we found that PROX1 displays a strong and highly 
dynamic expression pattern during NoR development. Moreover, we demonstrated using in 
vivo cell tracing, that sNCCs are the source of the PROX1-positive cells within the NoR. Our 
results indicate that PROX1 is the first marker that specifically identifies sNCCs. This might 
help to better identify the role of the different neural crest cell populations in distal gut 
innervation, and consequently to improve the diagnosis of diseases linked to incomplete ENS 
formation, such as Hirschsprung's disease. 
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1 - INTRODUCTION 
The gastrointestinal (GI) tract is a complex organ and its functioning relies on the coordinated 
work of many different tissue types. Indeed, GI smooth muscle, which is innervated by the 
enteric nervous system (ENS), allows the movement of the ingested food, while the intestinal 
epithelium and vascular system play a key role in nutrient absorption (Le Guen et al., 2015). 
Throughout development, the establishment and differentiation of all GI components are 
precisely regulated. The ENS, which is a complex network of neurons and glial cells, derives 
from Neural Crest Cells (NCCs) that colonize the immature GI tract from adjacent tissues 
(Furness, 2005; Uesaka et al., 2016). Specifically, during development, NCCs located at the 
boundary of the neural plate and non-neural ectoderm undergo epithelial-mesenchymal 
transition, delaminate from the ectoderm, and migrate through specific pathways to reach 
their targets where they finally differentiate (Le Douarin and Kalcheim, 1999). Bird models 
have been used for decades to study NCC migratory routes (for review, Heanue et al., 2016). 
Experiments with chick-quail chimaeras have identified two NCC types that form the ENS of 
the GI tract: vagal NCCs (vNCCs) and sacral NCCs (sNCCs). vNCCs migrate ventrally from 
the neural tube at the level of somites 1-7 on embryonic day 3 (E3) (Yntema and Hammond, 
1954; Le Douarin and Teillet, 1973; Espinosa-Medina et al., 2017). They first accumulate in 
caudal branchial arches before entering the foregut mesenchyme. In the GI tract, vNCCs 
migrate rostro-caudally, reaching the posterior end at E8-E8.5 in chicken embryos (Le 
Douarin and Teillet, 1973; Burns and Le Douarin, 1998). Interestingly, their migratory 
behavior within the GI mesenchyme changes along the anterior-posterior axis. In the pre-
umbilical gut, vNCCs are evenly distributed within the mesenchyme, while in the post-
umbilical gut they accumulate in the mesenchyme outermost layer. Finally, they reach the 
hindgut where they colonize the inner submucosa layer.  
In chicken embryos, sNCCs originate in the neural tube from somite 28 onwards and give 
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rise first to the so-called Nerve of Remak (NoR; an extramural ganglionated structure) and the 
pelvic plexus. Then, they migrate to the colon mesenchyme where they contribute to 20% of 
hindgut neurons (Le Douarin and Teillet, 1973; Serbedzija et al., 1991; Catala et al., 1995; 
Burns and Le Douarin, 1998; Burns et al., 2000; Nagy et al., 2007). The pelvic plexus is 
found both in avian and mammalian embryos (Nagy et al., 2007; Serbedzija et al., 1991; 
Kapur, 2010; Wang et al., 2011a). Conversely, the NoR is unique to birds, and runs in the 
mesentery, dorsal to the gut, from the cloaca to the duodenum (Suzuki et al., 1996). The NoR 
sends many nerve branches to the gut derivatives (intestine, cloaca, bursa of Fabricius), and 
also to other visceral organs, such as ovary and oviduct (Liu et al., 2009). 
Thus, vNCCs migrate in a rostro-caudal direction to the gut mesenchyme and colonize the 
entire chick gut by E8.5, whereas sNCCs enter the distal hindgut mesenchyme in a caudo-
rostral direction (Burns and Le Douarin, 1998; Burns and Le Douarin, 2001). It was 
previously suggested that sNCC migration is dependent on vNCC colonization. However, in 
the absence of vNCCs after vagal neural tube ablation, sNCC migrate in an apparently normal 
manner (Burns and Le Douarin, 2001). Conversely, when the sacral neural tube is 
transplanted to the vagal area, sNCC migrate rostro-caudally along the gut and stop migrating 
at the level of the caecum before the colon (Burns et al., 2002). As the hindgut is the GI 
region most frequently affected by developmental disorders linked to NCC failure to colonize 
the gut, such as aganglionic megacolon in animals and Hirschsprung’s disease in humans, the 
identification of intrinsic molecular differences between vNCC and sNCC is of great interest 
(Kapur, 2001; Burns and Le Douarin, 2001). Key ENS genes are expressed in both NCC 
types without qualitative differences (Delalande et al., 2008). Only RET expression is 4-fold 
higher in vNCCs than in sNCCs. Moreover, RET overexpression in sNCCs leads to the earlier 
migration to the gut of a larger number of cells (Delalande et al., 2008). However, no specific 
marker for vNCCs or sNCCs has been identified so far. 
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Using a microarray approach to identify candidate genes involved in GI development (Le 
Guen et al., 2009) that already allowed us to characterize regulators of GI mesenchyme 
development and differentiation (Notarnicola et al., 2012; McKey et al., 2016), we identified 
Prospero-related homeobox 1 (PROX1), a homeodomain transcription factor with a key role 
in cell type specification in various organs and tissues (Stergiopoulos et al., 2015). In mouse 
embryos, Prox1 plays an essential role in organ formation, especially brain, retina, lens, liver, 
pancreas, and the endothelial lymphatic system (Oliver et al., 1993; Tomarev et al., 1996; 
Wigle and Oliver, 1999; Wigle et al., 1999; Sosa-Pineda et al., 2000; Dyer et al., 2003; Wang 
et al., 2005; Lavado and Oliver, 2007). In the chick neural tube, PROX1 is strongly expressed 
in interneuron progenitors during development (Misra et al., 2008; Kaltezioti et al., 2010). 
Moreover, PROX1 regulates cell cycle exit of neural progenitor cells and binary fate decision 
(Kaltezioti et al., 2014). In the present study, we investigated PROX1 temporal and spatial 
expression in the developing chick colon. We found that PROX1 expression is strong and 
highly dynamic during the development of the NoR and the pelvic plexus. We also showed by 
in vivo cell tracing that sNCCs initially located in the neural tube from somite 28 onwards are 
at the origin of the PROX1-positive cells present in the NoR. 
 
2 – MATERIALS AND METHODS 
2.1 – Animals 
Timed fertilized white Leghorn eggs (Haas Farm, France) were kept at 38°C in a humidified 
incubator (Coudelou, France) until use. Embryos were staged according to Hamburger and 
Hamilton (HH) (Hamburger and Hamilton, 1951). GI tissues were dissected from chick 
embryos and staged according to the embryonic day (E) (Southwell, 2006). Dissected GI 
tissues were fixed in 4% paraformaldehyde at room temperature for 1h, washed in PBS, 
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gradually dehydrated in methanol and stored at -20°C before processing for whole-mount in 
situ hybridization, as described below. 
2.2 – Whole-mount in situ hybridization  
Whole-mount in situ hybridization was carried out as previously described using antisense 
SOX10 (Moniot et al., 2004; Bourret et al., 2017) and PROX1 riboprobes. For this, E6 GI tract 
total RNA and primers specific for chick PROX1 (Gene Bank ID: NM_001005616.1; 
forward: 5’ -TGT AAA GTT CAA CAG ATG CAT TAC C- 3’, reverse: 5’ -ATG TTA AGG 
GTC TCG GGC AA- 3’) were used to amplify chick PROX1 cDNA. The resulting 616 base 
pair (bp) fragment was cloned in the pGEM-T Easy vector (Invitrogen) and sequenced to 
verify the identity.   
GI tissues were gradually rehydrated in PBS, washed in PBS/0.1% Tween (PBT) and 
incubated in 6% hydrogen peroxide for 1h (Sigma, France). Samples were then permeabilized 
by treatment with proteinase K (10 µg/ml) for 10 min, washed with glycine in PBT, and fixed 
in 4% paraformaldehyde/0.2% glutaraldehyde in PBT for 20 min. Then, samples were 
hybridized with digoxigenin-labeled (Roche) antisense SOX10 or PROX1 riboprobes at 70°C 
overnight. After washes at 70°C, samples were incubated in 10% sheep serum at room 
temperature for 2.5h, and finally mixed with a pre-adsorbed anti-digoxigenin antibody 
coupled with alkaline phosphatase (Roche) at 4°C overnight. Complexes were detected with 
BM Purple, a chromogenic substrate for alkaline phosphatase (Roche).  
 
2.3 – Quantitative real-time RT-PCR  
Total RNA was extracted from E5 to E12 chick colons with the HighPure RNA Isolation Kit 
(Roche). Reverse transcription (RT) was performed with the Verso cDNA Synthesis Kit 
(Thermo Scientific) and quantitative real time PCR was performed using the LightCycler 
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technology (Roche Diagnostics). PCR primers (Supplementary Table 1) were designed using 
the LightCycler Probe Design software-2.0. For each developmental stage, each analyzed 
sample corresponded to total RNA pooled from three individual colons. Three samples were 
used at each stage to evaluate the expression of PROX1, SOX10 and SM22. Expression levels 
were determined with the LightCycler analysis software (version 3.5) relative to standard 
curves. Data were presented as the expression levels of PROX1, SOX10 and SM22 relative to 
the expression of the reference gene GAPDH. The relative mRNA expression was calculated 
using the 2-ΔΔCT method (Faure et al., 2015; McKey et al., 2016). Among the eight reference 
genes tested, GAPDH was selected based on its expression stability using the geNorm 
software. According to this program, GAPDH M value was 0.24, well below the accepted cut-
off for expression stability (i.e., 0.5) (Vandesompele et al. 2002). 
 
2.4 – Antibodies 
The anti-TUJ1 antibody (Covance, Princeton, NJ, USA; mouse monoclonal, cat. 
#MMS-435P, RRID: AB_10063408) was raised against microtubules derived from rat brain 
and recognizes an epitope located within the last 15 C-terminal residues of neuron-specific 
class III β tubulin (Lee MK et al., 1990). It cross-reacts with avian class III β tubulin, but not 
with tubulin in glial cells. The anti-HNK-1 antibody (LabVision/Neo-Markers, CA, USA; 
mouse monoclonal, cat. #MS-1163-P1, RRID: AB_63793) recognizes a N-linked 
carbohydrate (Abo and Balch, 1981) and is a well-known avian neural crest marker (Bronner-
Fraser, 1986; Moniot et al., 2004; Nagy et al., 2007; Faure et al., 2015; Bourret et al., 2017). 
The anti-HUC/D antibody (Invitrogen; mouse monoclonal, clone 16A11, cat. #A-21271, 
RRID: AB_221448) specifically recognizes neuronal perikarya (Marusich et al., 1994; 
Notarnicola et al., 2012). The anti-PROX1 antibody (RELIA Tech, Germany; rabbit 
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polyclonal, cat. #102-PA32, RRID: AB_10013821) used in this study was generated against 
the highly conserved C-terminus of recombinant human PROX1 produced in E. coli (amino 
acid 546 to 737, 100% identical to avian PROX1). In western blot experiments with E15 
chick pancreas-duodenum samples, the anti-PROX1 antibody identified a single band of 
around 83 kDa that corresponds to the predicted size of chick PROX1 (Supplementary Figure 
1a). Moreover, this antibody detected PROX1-positive cells in chick E15 pancreatic 
epithelium (Supplementary Figure 1b), consistent with a previous report (Westmoreland et al., 
2012). Finally, PROX1 immunostaining was comparable to the results obtained by in situ 
hybridization with the antisense PROX1 probe. 
 
2.5 – Immunofluorescence experiments 
Chick gut samples were fixed in 4% paraformaldehyde, followed by gradual incubation in 
sucrose solution. Then, samples were embedded in OCT and stored at -80°C before cutting 10 
µm cryosections collected on poly-d-lysine-coated slides (Thermo Fisher). 
Immunofluorescence experiments were performed using antibodies against PROX1 
(Reliatech; rabbit, dilution 1/400), TUJ1 (Covance; mouse, dilution 1/500), GFP 
(ThermoFisher; clone 3E6, mouse, cat. A-11120, RRID: RRID:AB_221568, dilution 1/400) 
and HNK-1 (NeoMarkers; mouse, dilution 1/200). Nuclei were labeled with Hoechst 33342 
(Invitrogen, France). After washing, slides were incubated with Alexa 488 anti-mouse 
(Thermo Fischer Scientific; cat. #A-21202, RRID:AB_141607, 1:2000 dilution) and Alexa 
555 anti-rabbit (Thermo Fischer Scientific; cat. #A32794, RRID:AB_2762834, 1:2000 
dilution) or Alexa 647 anti-rabbit (Thermo Fischer Scientific; cat. A-31573, 
RRID:AB_2536183, 1:2000 dilution) for 30min. Sections were rinsed and mounted with 
Fluorescent Mounting Medium (Dako, France). Immunofluorescence control experiments 
were performed without primary antibodies (data not shown). Cells were imaged with a Zeiss 
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AxioVision fluorescence microscope using standard filters, or a ZEISS LSM800 confocal 
laser scanning microscope. PROX1-positive cells in the developing NoR were quantified with 
the Fiji image analysis software. Image background was removed using on a “rolling ball” 
algorithm, and a median filter was applied followed by thresholding. Images were converted 
to a binary format and the areas of interest were selected and measured (TUJ1-positive area; 
µm2). PROX1 cells were then counted in such areas using the “analyze particle” plugin. The 
percentage of PROX1-positive cells per TUJ1-positive area (µm2) was calculated using the 
Prism7 software. 
 
2.6 – In ovo electroporation to target sNCCs 
Chick eggs were incubated for about 2.5 days until HH16 when integrative plasmids 
(pCAGGS-T2TP and pT2K-CAGGS-EGFP) (Wang et al., 2011b) were injected in the caudal 
neural tube (somite 25) using a micro-injector and the site was identified with Phenol Red 
Solution (Sigma, ref.: P0290). After microinjection, gold plated electrodes (Electroporation 
System ECM 830, BTX) were placed on both sides of the caudal neural tube and 
electroporation was performed bilaterally at 25V (3 pulses of 5ms) (Fort et al., 2011). Then, 
eggs were sealed and incubated up to E6.5. After colon dissection, GFP signal was directly 
evaluated before immunofluorescence analysis. 
 
3 – RESULTS 
3.1 – PROX1 expression in the chick embryonic gastrointestinal tract  
Among the genes with high expression level in the developing chick colon compared with the 
developing stomach identified by RNA microarray assays (Supplementary Table 2), PROX1 
was strongly expressed in E5 and E6 chick colon, and then its expression level decreased in 
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E9 colon. Conversely, it was faintly expressed in E6 and E9 stomach (Figure 1a). This pattern 
is unique compared with the expression of key NCC genes (SOX10 and RET) and markers of 
differentiated smooth muscle (SM22 and CNN1) (Figure 1a). Analysis of its expression 
pattern in the whole gastrointestinal tract at E6 by whole-mount in situ hybridization showed 
that PROX1 was expressed in the dorsal part of the colon and in pancreas (Figure 1b). As the 
NoR is situated in the dorsal part of the colon, the expression of SOX10, a marker of 
migrating NCCs, was also investigated by whole-mount in situ hybridization. At E6, SOX10 
signal revealed the presence of vNCCs in the gizzard, their advancing front at the level of the 
small intestine, and the presence of sNCCs in the NoR (Figure 1b), where PROX1 was also 
expressed. Analysis of PROX1 expression in the developing chick colon using an antibody 
that recognizes also the Gallus gallus PROX1 protein (Supplementary Figure 1) showed that 
PROX1 was expressed in the NoR (Figure 1c). Moreover, in E6 colon sections, PROX1 co-
localized with TUJ1-positive cells that define the NoR (Figure 1d) and also with HUC/D-
positive cells (a marker of neurons present in the NoR) (Figure 1e). Altogether, our data 
indicate that PROX1 is expressed by neurons of the NoR that are considered to originate from 
sNCCs (Le Douarin and Teillet, 1973; Serbedzija et al., 1991; Catala et al., 1995).   
 
3.2 – PROX1 expression in the developing chick colon 
As PROX1 was specifically expressed in the NoR, its temporal expression profile was 
thoroughly characterized and compared with that of SOX10 (NCC marker) in developing 
colon samples from E5 to E9 by whole-mount in situ hybridization (Figures 2a, 2b). At E5 
and E6, SOX10 expression in the colon was restricted to the NoR, thus identifying the sNCC 
population (Figure 2b). As vNCCs colonize the GI tract along an anterior-posterior migration 
axis, at E7 SOX10 expression in the small intestine, ceca and colon identified vNCCs. These 
cells then reached the most caudal part of the colon at E9 (Figure 2b). At E8, SOX10 
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expression highlighted the pelvic plexus surrounding the cloaca and connected to the NoR 
(Figure 2b and Supplementary Figure 2b, arrows). PROX1 was strongly expressed in the NoR 
from E5 (Figure 2a) and particularly at E6. In contrast to SOX10, PROX1 expression in the 
NoR quickly decreased from E7 onwards. At E8 PROX1 was faintly detected in the NoR, 
while its expression remained high in the pelvic plexus (Figure 2a and Supplementary Figure 
2a, arrows). Moreover, PROX1 defined fibers that are present in the caudal part of the E8 
colon and are connected to the NoR (Supplementary Figure 2a, arrowheads). At E9, PROX1 
could be detected in the pelvic plexus (Figure 2a, arrow), but not in the NoR. 
Quantification of PROX1, SOX10 (NCC marker) and SM22 (smooth muscle marker) 
expression levels by real-time quantitative RT-PCR (Figures 2c-e) using specific Gallus 
gallus primers (Supplementary Table 1) showed that SOX10 and SM22 transcript levels 
progressively increased during colon development from E5 to E12 (Figures 2d, 2e). PROX1 
was already strongly expressed at E5. Then, its expression increased at E6 and E7, and started 
to decrease from E8 (Figure 2c).  
Immunofluorescence analysis of PROX1 and TUJ1 (NCC marker in the NoR) protein 
expression in E6 to E9.5 colon transverse sections (Figure 3, Supplemental Figure 3) showed 
that at E8, TUJ1-positive cells were in the inner layer of the colon mesenchyme. This stage 
corresponds to the time of colonization by vNCCs (Figure 3, Supplemental Figure 3). In 
addition, TUJ1-positive cells were detected also in the outer layer of the colon mesenchyme 
starting from E7.5, which corresponds to the presence of sNCC in the colon (Figure 3, 
Supplemental Figure 3). During this period, PROX1-positive cells were observed in the NoR, 
and at E9.5 they could not be detected in the colon mesenchyme and in sNCCs that have 
already migrated to the mesenchyme (Figure 3; Supplementary Figure 3). Although PROX1 
expression was mainly restricted to the NoR, some PROX1-positive cells were located 
dorsally to the NoR and corresponded to developing lymphatic cells (white arrows, Figure 3). 
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Quantification of PROX1-positive sNCCs in the NoR revealed a strong decrease in their 
number from E6 (10.7x10-3 cells per µm2) to E9 (0.86x10-3 cells per µm2) (Figure 4). These 
findings show that PROX1 is dynamically expressed in the developing chick colon and 
accurately defines the population of sNCCs that reside in the NoR and in the pelvic plexus 
from E6 to E9.  
 
3.3 – Origin of the PROX1-positive cells detected in the nerve of Remak 
As sNCCs originate from NCCs present in the neural tube adjacent to somite 28 caudal-
wards, PROX1 spatiotemporal expression pattern was examined also during early 
development from HH11 (E2) to HH24 (E4.5). Whole-mount in situ hybridization showed 
that PROX1 was expressed in the developing eye, cranial neural tube, heart, liver, and optic 
and otic placodes. At HH24, PROX1 was observed in somites and mid-neural tube (Figure 
5a). However, at these stages, PROX1 expression could not be detected in the caudal neural 
tube where sNCCs originate (Figure 5a). Then, analysis of the expression of PROX1 and 
HNK-1 (a marker of migrating NCCs) by immunofluorescence in caudal colon transversal 
sections from HH18 to HH23 embryos (Figures 5b-d) showed that at HH18 and HH19, HNK-
1-positive sNCCs delaminated from the neural tube and migrated to the embryo body to reach 
the dorsal part of the colon and form the future NoR (Figures 5b, 5c). At HH18 and HH19, 
PROX1 was expressed in cells localized in the neural tube and in isolated cells that will 
constitute the lymphatic vessels (Figures 5b, 5c), but not in sNCCs (Figures 5b, 5c). 
Conversely, at HH23, PROX1 was expressed in HNK-1-positive cells that constitute the 
developing NoR (Figures 5d, 5e).  
As PROX1 was not expressed in migrating sNCCs that have not reached the NoR yet, 
sNCCs located at the level of somite 28 and caudal-wards were labeled by bilateral 
electroporation of integrative GFP plasmids in the neural tube at HH16 before delamination 
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(Figure 6a). At E6.5, most GFP-expressing cells were in the most dorsal part of the colon 
(Figure 6b). Immunofluorescence analysis of GFP and PROX1 expression in E6.5 colon 
samples after electroporation showed that GFP-positive cells in the NoR expressed also 
PROX1 (Figure 6c). Moreover, confocal microscopy analysis indicated that GFP-positive 
cells in the NoR expressed both PROX1 and HUC/D (Figure 6d), demonstrating that the 
PROX1-positive cells in the developing NoR are sNCCs from the caudal neural tube.  
 
4 – DISCUSSION  
The ENS derives from NCCs that originate from multiple positions to form a complex 
network of neurons and glial cells. Among them, sNCCs contribute to the intrinsic innervation 
of the posterior gut in vertebrates (Le Douarin and Teillet, 1973; Serbedzija et al., 1991; 
Catala et al., 1995; Burns and Le Douarin, 1998; Burns et al., 2000; Nagy et al., 2007; 
Serbedzija et al., 1991; Kapur, 2000; Wang et al., 2011a). A failure in NCC colonization of 
the gut leads to an incomplete formation of ENS (agangliogenesis) in the distal gut, a 
congenital obstructive disorder named the Hirschsprung's disease (de Santa Barbara et al., 
2002; Amiel et al., 2008; Etchevers et al., 2019). Unfortunately, the mechanisms leading to 
this pathology are not fully understood. A better knowledge about NCC development and the 
contribution of the different NCC populations to the distal gut innervation might improve 
their diagnosis. Although the origin and pathways of sNCC delamination and colonization are 
well described in avian and mouse models (Haenue et al., 2016; Kapur, 2000; Wang et al., 
2011a), no specific sNCC marker has been described so far (Haenue et al., 2016; Memic et 
al., 2018).  
Using microarray, in situ hybridization and immunofluorescence approaches, we found 
that PROX1 is expressed in the NoR located dorsally to the colon and small intestine from E5 
to E8. PROX1 is downregulated when sNCCs migrate to the colon/small intestine around 
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E7.5-E8. As in situ hybridization and immunofluorescence approaches are not quantitative 
techniques, we quantified by RT-PCR the relative abundance of PROX1 transcripts during 
colon development. We confirmed PROX1 dynamic expression and its downregulation at E8-
E9, when sNCCs migrate to the colon mesenchyme. Interestingly, at these stages, no 
expression of PROX1 was detected in SOX10-positive vNCCs that were migrating anterior-
posteriorly. The integrative expression of GFP in sNCCs before their migration to the NoR 
confirmed that PROX1-expressing cells found in the NoR at E6 derive from sNCCs. In 
vertebrates (birds, humans and mice), sNCCs form the pelvic plexus that contribute to the 
hindgut ENS (Serbedzija et al., 1991; Kapur, 2000; Nagy et al., 2007; Wang et al., 2011a).  
PROX1 is also expressed in the pelvic plexus at E8 and E9. In vertebrate, PROX1 is 
implicated in cell type specification in various organs and tissues (Stergiopoulos et al., 2015), 
but its role in ENS organization has not been addressed yet. In heterozygous mice in which 
Prox1 was inactivated by in-frame insertion of the lacZ gene, lacZ expression was observed in 
the dorsal part of the caudal hindgut (Burke and Oliver, 2002), where the pelvic plexus is 
located (Wang et al., 2011a). Moreover, high resolution in situ hybridization in mouse embryo 
sections demonstrated Prox1 expression in the dorsal part of the caudal hindgut at E14.4 
(https://gp3.mpg.de/GP-IMG/JPG/EG/EG00000615/EG00000615_00013B.jpg). Altogether, 
PROX1 expression in the NoR and also in the pelvic plexus suggests that PROX1 could be a 
specific marker of sNCCS.  
PROX1 is a member of the homeobox transcription factor family and through its 
homeobox domain can regulate positively or negatively the transcription of target genes 
(Stergiopoulos et al., 2015). For instance, Kaltezioti and colleagues showed that PROX1 
represses NOTCH1 signaling in the chick and mouse neural tube (Kaltezioti et al., 2010). As 
NOTCH1 signaling inhibits neurogenesis, PROX1 repression of NOTCH1 activity leads to 
neural progenitor cell differentiation. NOTCH1 and SOX10 maintain the ENS progenitor pool 
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and later promote neurogenesis and/or gliogenesis through additional regulatory mechanisms 
at different developmental stages. Our results show that SOX10 is expressed in the NoR, in 
migrating sNCCs and in vNCCs from E5 to E9. Conversely, PROX1 is only expressed in the 
NoR between E5 and E8 before sNCC migration to the colon/small intestine. PROX1 could 
have a role in the mechanisms that regulate the dual function of SOX10 and NOTCH1. It 
could be hypothesized that in the NoR, SOX10 and NOTCH1 maintain the sNCC pool of 
progenitors before PROX1 expression. Upon PROX1 expression, NOTCH1 starts to be 
downregulated and this induces neuronal differentiation. Then, PROX1 downregulation might 
lead to upregulation of NOTCH1 that together with SOX10 can now induce gliogenesis. 
However, although NOTCH1 can also contribute to NCC migration when PROX1 is still 
expressed in the NoR, some sNCCs are already migrating to the colon. Another pathway 
involved in ENS development is the HEDGEHOG signaling cascade that has a role in NCC 
migration and could inhibit the NOTCH pathway (Liu and Ngan, 2014; Nagy et al., 2016). 
New studies are now needed to identify PROX1 downstream targets, which will also lead to 
the discovery of more sNCC-specific markers, providing new tools for the characterization of 
colon ENS-associated pathologies. Altogether, our results have identified a novel NCC 
marker that allows the distinction between vNCCs and sNCCs.  
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FIGURE LEGENDS  
 
FIGURE 1 Spatial and temporal expression of PROX1 mRNA during embryonic 
development of the chick GI tract. Heatmap for PROX1, SM22, CNN1, SOX10 and RET 
expression in chick colon (from E5, E6, and E9) and gizzard (E6 and E9) samples (a).  
Highest signals are in red, and lowest signals are in green. PROX1 mRNA is dynamically 
expressed in colon compared to gizzard. SM22 and CNN1 are two markers of differentiated 
smooth muscle. Whole-mount in situ hybridization analysis of PROX1 and SOX10 (b) in the 
E6 chick GI tract. PROX1 is expressed in pancreas, and the dorsal part of the colon. SOX10 
staining showed the presence of vagal NCCs in the gizzard and mid-small intestine. SOX10 
also is expressed in the NoR localized in the dorsal part of the colon. Unspecific PROX1 
probe trapping is observed in the lumen of the gizzard. Scale bar: 1 mm. Abbreviations: col.: 
colon; giz: gizzard; lg: lung; NoR: Nerve of Remak; panc: pancreas; s.i.: small intestine. 
Immunohistochemistry analysis of PROX1 expression in E7 chick colon cryostat sections 
(representative image) (c). PROX1-positive cells are mainly observed in the NoR. Scale Bar: 
100 µm. (d) Immunofluorescence analysis using anti-PROX1 and -TUJ1 antibodies in E6 
chick colon sections (upper part of the colon). PROX1 (nuclear expression) and TUJ1 
(cytoplasmic expression) are co-localized in the NoR. Scale Bars: 25 µm. (e) Confocal 
immunofluorescence analysis of PROX1 and HUC/D expression in E6 chick colon sections 
(lower part of the colon). Nuclear PROX1 and HUC/D are co-expressed in neurons of the 
NoR. Scale Bars: 25 µm.  Abbreviations: Epith.: epithelium; NoR: Nerve of Remak. 
 
FIGURE 2 Spatial and temporal expression of PROX1 mRNA in the chick developing colon. 
Whole-mount in situ hybridization analysis of PROX1 (a) and SOX10 (b) in E5 to E9 chick 
colon samples. Scale Bars: 1 mm. PROX1 expression is detected in the NoR from E5 to E8, 
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but not at E9. In addition, PROX1 expression is observed in the pelvic plexus (PP) at E8 and 
E9. SOX10 expression is restricted to the NoR at E5 and E6. Moreover, SOX10 is also 
observed in migrating vNCCs located in the small intestine and ceca at E7 and in the colon 
and pelvic plexus (PP) at E8 (arrowheads). At E9, the whole colon is completely colonized by 
NCCs and SOX10 is exclusively expressed by the glial lineage. Relative mRNA expression 
levels of PROX1 (c), SOX10, (d) and SM22 (e) in pooled E5 to E12 colon samples determined 
by quantitative RT-PCR. Data shown are the mean ± SD expression levels relative to 
GAPDH. Each measurement was done using total RNA pooled from three individual colons 
(three pools for each stage). PROX1 mRNA levels is highest at E6. SOX10 and SM22 
expression levels progressively increase during colon development.  
 
FIGURE 3 Spatial and temporal expression of PROX1 protein in the chick developing colon.  
Immunofluorescence analysis of PROX1 and TUJ1 expression in transverse cryosections 
from E6 to E9 chick colons. TUJ1 is detected in sNCCs located in the NoR from E6 to E9. At 
E8, numerous TUJ1-positive sNCCs migrated to the outer part of the colon mesenchyme. In 
addition, at E8 TUJ1-positive vNCCs are present in the inner part of the colon mesenchyme. 
Two enteric plexuses are present at E9: the myenteric (MP) and submucosa (SP) plexus. At 
E6, PROX1 is observed in the majority of cells present in the NoR. Then, PROX1 expression 
in these cells decreased from E7 to E8, and remained only in some isolated cells at E9. 
PROX1 is also expressed in lymphatic endothelial cells (white arrows) located close to the 
NoR. Scale Bars: 100 µm.   
 
FIGURE 4 Quantification of the number of PROX1-positive cells in the NoR at E6 to E9 
(data from Figure 3). The number of cells in which PROX1 is detected in the nucleus was 
determined relative to the TUJ1-positive cell area in the NoR (n=2-4 colon/small intestine 
 20 
sections/stage). The number of PROX1-positive cells progressively decreased over time: 
10.7x10-3 cells/µm2 at E6, 6.19x10-3 cells/µm2 at E7, 3.89x10-3 cells/µm2 at E8, and 0.86x10-3 
cells/µm2 at E9. Data are the mean ± SD. 
 
FIGURE 5 PROX1 expression in early developing chick colon. PROX1 mRNA expression 
was analyzed by whole-mount in situ hybridization in Hamburger and Hamilton Stage 11 
(HH11) to HH23 embryos (a). PROX1 is expressed in the developing eye, cranial neural tube 
(cNT), heart, liver, optic (op. pl.) and otic (ot. pl.) placodes. At HH24, PROX1 expression is 
observed in somites and mid-neural tube. Scale Bars: 1 mm. Immunofluorescence analysis of 
PROX1 and HNK-1 expression in transverse cryosections of HH18 to HH23 chick embryos at 
the posterior splanchnic mesoderm (spl. m.) and gut levels (b, c, d). At HH18 and HH19, 
HNK-1-positive sNCCs delaminate from the neural tube (NT) to reach the colon (Col.) and to 
form first the NoR at HH23. PROX1- and HNK-1-positive cells are only observed at HH23 
when the NoR is formed. Scale Bars: 50 µm. Immunofluorescence analysis of PROX1 and 
HNK-1 expression in sagittal cryosections of HH23 chick embryos (e). Co-expression of 
PROX1 and HNK-1 is observed along the dorsal part of the colon (Col.) in the developing 
NoR. Scale Bars: 100 µm.   
 
FIGURE 6 Origin of PROX1-expressing cells present in the NoR. Electroporation procedure 
to target sNCCs before their delamination from the neural tube (a). Integrative GFP-
expressing plasmids were injected in the caudal neural tube at HH16 with Phenol Red 
Solution. After electroporation, eggs were put back in the incubator. Representative image to 
show the electroporation efficiency in targeting the neural tube (NT) at 24h post-injection, 
before sNCC migration (a). Representative image of an E6.5 chick colon after integrative 
GFP plasmid electroporation at HH16 observed with white light and with a fluorescence 
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stereomicroscope (b). Electroporated sNCCs are observed in the E6.5 NoR located dorsally to 
the colon (Col.). Immunofluorescence analysis of PROX1 and GFP expression in E6.5 colon 
transverse cryosections after electroporation at HH16 to visualize the NoR (c). Confocal 
immunofluorescence analysis of PROX1, HUC/D and GFP expression in E6.5 colon 
transverse cryosections after electroporation at HH16 to visualize the NoR (d). Cells that co-
express GFP, PROX1 and HUC/D are observed in the NoR. Epith: epithelium.  
 
 
 
 
 
 22 
REFERENCES 
 
Abo T, Balch CM. 1981. A differentiation antigen of human NK and K cells identified by a 
monoclonal antibody (HNK-1). J Immunol 127:1024-1029. 
Amiel J, Sproat-Emison E, Garcia-Barcelo M, Lantieri F, Burzynski G, Borrego S, Pelet A, 
Arnold S, Miao X, Griseri P, Brooks AS, Antinolo G, de Pontual L, Clement-Ziza M, 
Munnich A, Kashuk C, West K, Wong KK, Lyonnet S, Chakravarti A, Tam PK, 
Ceccherini I, Hofstra RM, Fernandez R; Hirschsprung Disease Consortium. 2008. 
Hirschsprung disease, associated syndromes and genetics: a review. J Med Genet 45:1-
14. 
Bourret A, Chauvet N, de Santa Barbara P, Faure S. 2017. Colonic mesenchyme differentiates 
into smooth muscle before its colonization by vagal enteric neural crest-derived cells in 
the chick embryo. Cell Tissue Res 368:503–511. 
Bronner-Fraser M. 1986. Analysis of the early stages of trunk neural crest migration in avian 
embryos using monoclonal antibody HNK-1. Dev Biol 115:44-55. 
Burke Z, Oliver G. 2002. Prox1 is an early specific marker for the developing liver and 
pancreas in the mammalian foregut endoderm. Mech Dev 118:147-155. 
Burns AJ, Le Douarin NM. 1998. The sacral neural crest contributes neurons and glia to the 
post-umbilical gut: spatiotemporal analysis of the development of the enteric nervous 
system. Development 125:4335–4347. 
Burns AJ, Champeval D, Le Douarin NM. 2000. Sacral neural crest cells colonise aganglionic 
hindgut in vivo but fail to compensate for lack of enteric ganglia. Dev Biol 219:30–43. 
Burns AJ, Le Douarin NM. 2001. Enteric nervous system development: analysis of the 
selective developmental potentialities of vagal and sacral neural crest cells using quail-
chick chimeras. Anat Rec 262:16-28. 
 23 
Burns AJ, Delalande JM, Le Douarin NM. 2002. In ovo transplantation of enteric nervous 
system precursors from vagal to sacral neural crest results in extensive hindgut 
colonisation. Development 129:2785–2796. 
Catala M, Teillet MA, Le Douarin NM. 1995. Organization and development of the tail bud 
analyzed with the quail-chick chimaera system. Mech Dev 51:51-65.  
de Santa Barbara P, van den Brink GR, Roberts DJ. 2012. Molecular etiology of gut 
malformations and diseases. Am J Med Genet 115:221-230.  
Delalande JM, Barlow AJ, Thomas AJ, Wallace AS, Thapar N, Erickson CA, Burns AJ. 2008. 
The receptor tyrosine kinase RET regulates hindgut colonization by sacral neural crest 
cells. Dev Biol 313:279–292. 
Dyer MA, Livesey FJ, Cepko CL, Oliver G. 2003. Prox1 function controls progenitor cell 
proliferation and horizontal cell genesis in the mammalian retina. Nat Genet 34:53–58. 
Espinosa-Medina I, Jevans B, Boismoreau F, Chettouh Z, Enomoto H, Müller T, Birchmeier 
C, Burns AJ, Brunet J-F. 2017. Dual origin of enteric neurons in vagal Schwann cell 
precursors and the sympathetic neural crest. Proc Natl Acad Sci USA 114:11980–11985. 
Etchevers HC, Dupin E, Le Douarin NM. 2019. The diverse neural crest: from embryology to 
human pathology. Development 146:pii: dev169821. 
Faure S, McKey J, Sagnol S, de Santa Barbara P. 2015. Enteric neural crest cells regulate 
vertebrate stomach patterning and differentiation. Development 142:331–342. 
Fort P, Guémar L, Vignal E, Morin N, Notarnicola C, de Santa Barbara P, Faure S. 2011. 
Activity of the RhoU/Wrch1 GTPase is critical for cranial neural crest cell migration. 
Dev Biol 350:451-463.  
Furness JB. 2005. The Enteric Nervous System. Blackwell Publishing. Oxford. 
Hamburger V, Hamilton HL. 1951. A series of normal stages in the development of the chick 
embryo. J Morphol 88:49-92. 
 24 
Heanue TA, Shepherd IT, Burns AJ. 2016. Enteric nervous system development in avian and 
zebrafish models. Dev Biol 417:129-138. 
Kaltezioti V, Antoniou D, Stergiopoulos A, Rozani I, Rohrer H, Politis PK. 2014. Prox1 
regulates Olig2 expression to modulate binary fate decisions in spinal cord neurons. J 
Neurosci 34:15816–15831. 
Kaltezioti V, Kouroupi G, Oikonomaki M, Mantouvalou E, Stergiopoulos A, Charonis A, 
Rohrer H, Matsas R, Politis PK. 2010. Prox1 regulates the notch1-mediated inhibition of 
neurogenesis. PLoS Biol 8:e1000565. 
Kapur RP. 2000. Colonization of the murine hindgut by sacral crest-derived neural 
precursors: experimental support for an evolutionarily conserved model. Dev Biol. 
227:146-155.  
Lavado A, Oliver G. 2007. Prox1 expression patterns in the developing and adult murine 
brain. Dev Dyn 236:518–524. 
Le Douarin NM, Teillet MA. 1973. The migration of neural crest cells to the wall of the 
digestive tract in avian embryo. J Embryol Exp Morphol 30:31–48. 
Le Douarin NM, Kalcheim C, 1999. The Neural Crest (2nd edition). Cambridge University 
Press. UK. 
Le Guen L, Notarnicola C, de Santa Barbara P. 2009. Intermuscular tendons are essential for 
the development of vertebrate stomach. Development 136:791–801. 
Le Guen L, Marchal S, Faure S, de Santa Barbara P. 2015. Mesenchymal-epithelial 
interactions during digestive tract development and epithelial stem cell regeneration. Cell 
Mol Life Sci 72:3883-3896. 
Lee MK, Rebhun LI, Frankfurter A. 1990. Posttranslational modification of class III beta-
tubulin. Proc Natl Acad Sci U S A. 87:7195-7199. 
 25 
Liu J, Qin J, Feng Y, Bao H, Zhou Q, Chen Q. 2009 Distribution of vasoactive intestinal 
peptide and substance P messenger ribonucleic acid in intestinal nerve of Remak of 
chicken. Poult Sci 88:1421-1426. 
Liu JA, Ngan ES. 2014. Hedgehog and Notch signaling in enteric nervous system 
development. Neurosignals. 22:1-13  
Marusich MF, Furneaux HM, Henion PD, Weston JA. 1994. Hu neuronal proteins are 
expressed in proliferating neurogenic cells. J Neurobiol. 25:143-155. 
McKey J, Martire D, de Santa Barbara P, Faure S. 2016. LIX1 regulates YAP1 activity and 
controls the proliferation and differentiation of stomach mesenchymal progenitors. BMC 
Biol 14:34. 
Memic F, Knoflach V, Morarach K, Sadler R, Laranjeira C, Hjerling-Leffler J, Sundström E, 
Pachnis V, Marklund U. 2018. Transcription and Signaling Regulators in Developing 
Neuronal Subtypes of Mouse and Human Enteric Nervous System. Gastroenterology. 
154:624-636. 
Misra K, Mishra K, Gui H, Matise MP. 2008. Prox1 regulates a transitory state for 
interneuron neurogenesis in the spinal cord. Dev Dyn 237:393–402. 
Moniot B, Biau S, Faure S, Nielsen CM, Berta P, Roberts DJ, de Santa Barbara P. 2004. 
SOX9 specifies the pyloric sphincter epithelium through mesenchymal-epithelial signals. 
Development 131:3795–3804. 
Nagy N, Brewer KC, Mwizerwa O, Goldstein AM. 2007. Pelvic plexus contributes ganglion 
cells to the hindgut enteric nervous system. Dev Dyn 236:73-83. 
Nagy N, Barad C, Graham HK, Hotta R, Cheng LS, Fejszak N, Goldstein AM. 2016. Sonic 
hedgehog controls enteric nervous system development by patterning the extracellular 
matrix. Development. 143:264-75.  
 26 
Notarnicola C, Rouleau C, Le Guen L, Virsolvy A, Richard S, Faure S, De Santa Barbara P. 
2012. The RNA-binding protein RBPMS2 regulates development of gastrointestinal 
smooth muscle. Gastroenterology 143:687-697.e9. 
Oliver G, Sosa-Pineda B, Geisendorf S, Spana EP, Doe CQ, Gruss P. 1993. Prox 1, a 
prospero-related homeobox gene expressed during mouse development. Mech Dev 44:3–
16. 
Serbedzija GN, Burgan S, Fraser SE, Bronner-Fraser M. 1991. Vital dye labelling 
demonstrates a sacral neural crest contribution to the enteric nervous system of chick and 
mouse embryos. Development 111:857-866.  
Southwell BR. 2006. Staging of intestinal development in the chick embryo. Anat Rec A 
Discov Mol Cell Evol Biol 288:909-920. 
Sosa-Pineda B, Wigle JT, Oliver G. 2000. Hepatocyte migration during liver development 
requires Prox1. Nat Genet 25:254–255. 
Stergiopoulos A, Elkouris M, Politis PK. 2015. Prospero-related homeobox 1 (Prox1) at the 
crossroads of diverse pathways during adult neural fate specification. Front Cell Neurosci 
8:454. 
Suzuki M, Ohmori Y, Watanabe T. 1996. Projections of neurons in the intestinal nerve of 
Remak to the chicken intestine. J Auton Nerv Syst 61:79-86. 
Tomarev SI, Sundin O, Banerjee-Basu S, Duncan MK, Yang JM, Piatigorsky J. 1996. 
Chicken homeobox gene Prox 1 related to Drosophila prospero is expressed in the 
developing lens and retina. Dev Dyn 206:354–367. 
Uesaka T, Young HM, Pachnis V, Enomoto H. 2016. Development of the intrinsic and 
extrinsic innervation of the gut. Dev Biol 417:158–167. 
 27 
Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, et al. Accurate 
normalization of real-time quantitative RT-PCR data by geometric averaging of multiple 
internal control genes. Genome biology 2002;3(7):RESEARCH0034 
Wang J, Kilic G, Aydin M, Burke Z, Oliver G, Sosa-Pineda B. 2005. Prox1 activity controls 
pancreas morphogenesis and participates in the production of “secondary transition” 
pancreatic endocrine cells. Dev Biol 286:182–194. 
Wang X, Chan AK, Sham MH, Burns AJ, Chan WY. 2011a. Analysis of the sacral neural 
crest cell contribution to the hindgut enteric nervous system in the mouse embryo. 
Gastroenterology 141:992-1002. 
Wang H, Bonnet A, Delfini MC, Kawakami K, Takahashi Y, Duprez D. 2011b. Stable, 
conditional, and muscle-fiber-specific expression of electroporated transgenes in chick 
limb muscle cells. Dev Dyn 240:1223–1232. 
Westmoreland JJ1, Kilic G, Sartain C, Sirma S, Blain J, Rehg J, Harvey N, Sosa-Pineda B. 
2012. Pancreas-specific deletion of Prox1 affects development and disrupts homeostasis 
of the exocrine pancreas. Gastroenterology 142:999-1009. 
Wigle JT, Chowdhury K, Gruss P, Oliver G. 1999. Prox1 function is crucial for mouse lens-
fibre elongation. Nat Genet 21:318–322. 
Wigle JT, Oliver G. 1999. Prox1 function is required for the development of the murine 
lymphatic system. Cell 98:769–778. 
Yntema CL, Hammond WS. 1954. The origin of intrinsic ganglia of trunk viscera from vagal 
neural crest in the chick embryo. J Comp Neurol 101:515–541.  
 
 
 28 
 SUPPLEMENTAL FIGURE LEGENDS 
 
SUPPLEMENTAL FIGURE 1 Characterization of the rabbit anti-PROX1 antibody by 
western blot and immunofluorescence analysis. Western blot analysis using increasing 
concentrations of E15 pancreas-duodenum protein extracts demonstrated a unique band of 
about 83 kDa that corresponds to the predicted size of chick PROX1 (a). Immunofluorescence 
analysis of PROX1 expression in E15 chick pancreas cryostat sections (b). PROX1-positive 
cells are only observed in the pancreatic epithelium, with a nuclear localization.  Scale bar: 
100 µm.  
 
SUPPLEMENTAL FIGURE 2 Expression of PROX1 mRNA in the chick developing 
colorectum. Whole-mount in situ hybridization analysis of PROX1 (a) and SOX10 (b) in E8 
chick colons. PROX1 expression is observed in the NoR and the pelvic plexuses (PP, arrows) 
at E8. PROX1 expression is also present in fibers that connect the PP to the NoR 
(arrowheads). SOX10 expression is observed in the NoR, in migrating vNCCs and in the 
pelvic plexus (PP) at E8 (arrows). Scale Bars: 200 µm.  
 
SUPPLEMENTAL FIGURE 3 Spatial and temporal PROX1 expression in the chick 
developing colon.  Immunofluorescence analysis of PROX1 and TUJ1 expression in E6.5 to 
E9.5 chick colon transverse cryosections (focus on the NoR). TUJ1 is observed in sNCCs 
located in the NoR from E6.5 to E9.5. At E7.5, few TUJ1-positive sNCCs entered the outer 
part of the colon mesenchyme. At E6.5, PROX1 is observed in the majority of cells present in 
the NoR. PROX1 expression in these cells strongly decreased from E7.5 to E8.5 to finally be 
present only in some isolated cells at E9.5. PROX1 expression was also observed in 
lymphatic endothelial cells (white arrows) close to the NoR. Scale bars: 100 µm.   
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SUPPLEMENTAL TABLE 1 Gallus gallus primers used for RT-qPCR. 
 
SUPPLEMENTAL TABLE 2 Microarray data used for producing the Heatmap (Figure 1a) 
that summarizes the expression of PROX1, SM22, CNN1, SOX10 and RET in chick colon 
(from E5, E6, and E9) and gizzard (E6 and E9) samples, with their corresponding p values. 
 






Supplementary Table 1: Gene-specific Gallus Gallus  primers used for RT-qPCR.
Targets Forward primer (5'-3') Reverse primer (5'-3') Amplicon (bp)
PROX1 AAT CTC GCC CTA CTC GGG AA GGT AAT GCA TCT GTT GAA CTT TAC A 151
SOX10 GCA TCG GAC AAC TCT TCG CCA GTC ATA GCC GCT A 150
SM22 TGA GCA GGG ATG TCC AGT AGC CAA TGA TGT TCT TGC C 501
GAPDH CGT CCT CTC TGG CAA AG TCA CGC TCC TGG AAG ATA G 177
Supplementary Table 2: Microarray data used for
Heatmap in Figure 1a.
Microarray values
E5 Colon E6 Colon E9 Colon E6 Stomach E9 Stomach
PROX1 113,5168 201,6 72,06155 32,7 22,4
SM22 337,0399 479,7 844,1374 768,1 2757,9
CNN1 45,48849 148,1 769,3994 127,6 764,3
SOX10 53,06907 104,4 220,6422 224,1 216,2
RET 153,1164 301,4 319,4413 240,6 464,5
Microarray P  values
E5 Colon E6 Colon E9 Colon E6 Stomach E9 Stomach
PROX1 0,00024414 0,000244 0,00024414 0,00415 0,056152
SM22 0,00073242 0,000732 0,00024414 0,000732 0,000244
CNN1 0,00024414 0,000244 0,00024414 0,000244 0,000244
SOX10 0,00024414 0,023926 0,00024414 0,001953 0,00293
RET 0,00024414 0,000244 0,00024414 0,000244 0,000244
Relative values reported to the maximum of expression
E5 Colon E6 Colon E9 Colon E6 Stomach E9 Stomach
PROX1 0,56307937 1 0,35744816 0,16220238 0,11111111
SM22 0,12220889 0,17393669 0,30607977 0,27850901 1
CNN1 0,05912208 0,1924878 1 0,16584364 0,99337223
SOX10 0,23680977 0,46586345 0,98457028 1 0,96474788
RET 0,32963703 0,64886975 0,68771001 0,51797632 1



Graphical Abstract 
The Enteric Nervous System ensures the intrinsic innervation of the gastrointestinal tract and 
originates from vagal and sacral Neural Crest Cells. In birds, sacral Neural Crest Cells (sNCCs) 
first give rise to an extramural ganglionated structure: the Nerve of Remak (NoR) and the Pelvic 
Plexus. Later, sNCCs colonize the colon mesenchyme and contribute to the intrinsic innervation 
of the caudal part of the gut. Here, we show that PROX1 is expressed in sNCCs localized in the 
NoR and in the pelvic plexus. Using in vivo cell tracing, we demonstrated that sNCCs are the 
source of the PROX1-positive cells within the NoR. This work identifies PROX1 as a novel 
and thus far unique marker that defines sNCCs.  
 

